TAF9 Antikörper (AA 25-74)
Kurzübersicht für TAF9 Antikörper (AA 25-74) (ABIN6735958)
Target
Alle TAF9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 25-74
-
Spezifität
- Human TAF9
-
Homologie
- Percent identity by BLAST analysis:
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa25-74 of human TAF9 (Q9Y3D8, NP_001015891). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Rat (100%), Panda, Bovine, Pig (92%), Mouse, Chicken, Platypus (85%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: IHC, IHC-P, WB (0.12 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))
-
Andere Bezeichnung
- TAF9 / CINAP
-
Hintergrund
-
Name/Gene ID: TAF9
Synonyms: TAF9, AD-004, Adrenal gland protein AD-004, ATP-AMP transphosphorylase 6, CINAP, CGI-137, Coilin interacting protein, TAFII-32, TAFII32, STAF31/32, TAFII31, CIP, TAF2G, TAFII-31, TAFIID32 -
Gen-ID
- 6880
-
NCBI Accession
- NP_001015891
-
UniProt
- Q9Y3D8
-
Pathways
- Negative Regulation of intrinsic apoptotic Signaling
Target
-